133 related articles for article (PubMed ID: 21109080)
1. Correlation of biomarkers in head and neck squamous cell carcinoma.
Tse GM; King AD; Yu AM; Lam CC; Chan AW; Chen GG; Yeung DK; Yu KH; Bhatia KS; Chan AB
Otolaryngol Head Neck Surg; 2010 Dec; 143(6):795-800. PubMed ID: 21109080
[TBL] [Abstract][Full Text] [Related]
2. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Choline/Creatine and Apparent Diffusion Coefficient values with the prognostic parameters of Head and Neck Squamous Cell Carcinoma.
Razek AA; Nada N
NMR Biomed; 2016 Apr; 29(4):483-9. PubMed ID: 26867020
[TBL] [Abstract][Full Text] [Related]
5. Correlation of 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer.
Choi SH; Paeng JC; Sohn CH; Pagsisihan JR; Kim YJ; Kim KG; Jang JY; Yun TJ; Kim JH; Han MH; Chang KH
J Nucl Med; 2011 Jul; 52(7):1056-62. PubMed ID: 21680692
[TBL] [Abstract][Full Text] [Related]
6. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
7. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma.
Moertel S; Ackermann H; Baghi M; Eckardt A; Wagenblast J; Stöver T; Hambek M
Anticancer Res; 2011 Feb; 31(2):665-9. PubMed ID: 21378353
[TBL] [Abstract][Full Text] [Related]
9. Initial experience of 3-tesla apparent diffusion coefficient values in characterizing squamous cell carcinomas of the head and neck.
Srinivasan A; Dvorak R; Rohrer S; Mukherji SK
Acta Radiol; 2008 Nov; 49(9):1079-84. PubMed ID: 18785024
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
[TBL] [Abstract][Full Text] [Related]
11. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging.
Ljumanovic R; Langendijk JA; Hoekstra OS; Leemans CR; Castelijns JA
Eur J Radiol; 2006 Oct; 60(1):58-66. PubMed ID: 16829010
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
13. Proliferation-associated monoclonal antibodies: a useful tool for prognosis in squamous cell carcinomas of head and neck?
Lörz M; Meyer-Breiting E; Bettinger R; Desloovere C; Klima A
Acta Otorhinolaryngol Belg; 1989; 43(1):41-6. PubMed ID: 2801095
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
Do NY; Lim SC; Im TS
Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
[TBL] [Abstract][Full Text] [Related]
15. Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams.
Ahmed A; Cascarini L; Sandison A; Clarke P
Br J Oral Maxillofac Surg; 2012 Mar; 50(2):119-21. PubMed ID: 21450378
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of new serum tumor markers in head and neck squamous cell carcinoma.
Marcos CA; Martínez DA; de Los Toyos JR; Domínguez Iglesias F; Hermsen M; Guervós MA; Pendás JL
Otolaryngol Head Neck Surg; 2009 Mar; 140(3):375-80. PubMed ID: 19248946
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer.
Kong A; Leboucher P; Leek R; Calleja V; Winter S; Harris A; Parker PJ; Larijani B
Cancer Res; 2006 Mar; 66(5):2834-43. PubMed ID: 16510606
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI in head and neck cancer.
Hermans R; Vandecaveye V
JBR-BTR; 2007; 90(4):264-7. PubMed ID: 17966242
[TBL] [Abstract][Full Text] [Related]
20. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
Clin Cancer Res; 2004 Dec; 10(24):8451-9. PubMed ID: 15625067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
